SOPHROSYNE CAPITAL LLC filings

This page lists the SEC filings reported by SOPHROSYNE CAPITAL LLC.

SEC filings by SOPHROSYNE CAPITAL LLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2016-02-12SOPHROSYNE CAPITAL LLCASPEN GROUP, INC.1,690,4901.3%EDGAR
SC 13G/A2015-01-26SOPHROSYNE CAPITAL LLCASPEN GROUP, INC.11,012,8089.7%EDGAR
SC 13G/A2014-09-10SOPHROSYNE CAPITAL LLCASPEN GROUP, INC.11,012,8089.7%EDGAR
SC 13G/A2014-04-07SOPHROSYNE CAPITAL LLCMeetMe, Inc.1,855,8354.8%EDGAR
SC 13G/A2014-01-29SOPHROSYNE CAPITAL LLCASPEN GROUP, INC.6,041,8389.0%EDGAR
SC 13G/A2014-01-29SOPHROSYNE CAPITAL LLCMeetMe, Inc.2,210,8875.7%EDGAR
SC 13G/A2014-01-29SOPHROSYNE CAPITAL LLCVENTRUS BIOSCIENCES INC00.0%EDGAR
SC 13G/A2014-01-29SOPHROSYNE CAPITAL LLCVenaxis, Inc.00.0%EDGAR
SC 13G/A2013-10-01SOPHROSYNE CAPITAL LLCS&W Seed Co554,2134.8%EDGAR
SC 13G/A2013-09-23SOPHROSYNE CAPITAL LLCCardioNet, Inc.1,038,5184.1%EDGAR
SC 13G/A2013-08-22SOPHROSYNE CAPITAL LLCSMITH MICRO SOFTWARE INC1,827,9984.9%EDGAR
SC 13G2013-06-28SOPHROSYNE CAPITAL LLCS&W Seed Co610,5135.3%EDGAR
SC 13G/A2013-06-14SOPHROSYNE CAPITAL LLCCoastal Contacts Inc1,100,2633.4%EDGAR
SC 13G/A2013-04-05SOPHROSYNE CAPITAL LLCStereotaxis, Inc.00.0%EDGAR
SC 13G/A2013-04-05SOPHROSYNE CAPITAL LLCBIODELIVERY SCIENCES INTERNATIONAL INC1,595,4414.2%EDGAR
SC 13G/A2013-03-22SOPHROSYNE CAPITAL LLCS&W Seed Co403,4124.3%EDGAR
SC 13G/A2013-03-14SOPHROSYNE CAPITAL LLCACELRX PHARMACEUTICALS INC1,665,0634.5%EDGAR
SC 13G/A2013-02-15SOPHROSYNE CAPITAL LLCEnteroMedics Inc700,0001.6%EDGAR
SC 13G/A2013-02-13SOPHROSYNE CAPITAL LLCBIODELIVERY SCIENCES INTERNATIONAL INC2,259,2886.0%EDGAR
SC 13G/A2013-02-13SOPHROSYNE CAPITAL LLCAspenBio Phama Inc914,43210.0%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.